Jacobson Pharma Corporation Limited
HKEX:2633.HK
0.75 (HKD) • At close November 14, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | |||||||||||
| Nettowinst
| 319.028 | 251.044 | 177.666 | 173.71 | 214.494 | 250.561 | 202.27 | 179.328 | 145.61 | 136.135 | 216.948 |
| Afschrijvingen & Amortisatie
| 156.522 | 184.46 | 192.597 | 191.701 | 166.271 | 111.104 | 109.349 | 79.128 | 67.369 | 52.945 | 43.996 |
| Uitgestelde Inkomstenbelasting
| 0 | -301.227 | 0 | 0 | -386.177 | 33.827 | 80.141 | 0 | 0 | 0 | 0 |
| Aandelen Gebaseerde Vergoedingen
| 19.368 | 19.135 | 0 | 0 | 1.509 | 5.349 | 9.734 | 0 | 0 | 0 | 0 |
| Verandering in Werkkapitaal
| -13.725 | 86.828 | -0.443 | -0.212 | -52.126 | -39.176 | -89.875 | -93.295 | -30.729 | -2.856 | -19.04 |
| Vorderingen
| -68.272 | 23.779 | -62.788 | -38.821 | 0.002 | -21.668 | -50.935 | -44.48 | -2.901 | -2.731 | 1.739 |
| Voorraden
| -9.3 | -53.451 | 41.627 | 20.933 | -51.737 | -17.508 | -38.94 | -48.815 | -27.828 | -4.484 | -16.712 |
| Crediteuren
| 63.847 | 116.5 | 20.718 | 17.676 | -0.391 | 6.758 | -13.18 | -11.978 | 15.953 | 2.731 | -1.739 |
| Overig Werkkapitaal
| 0 | 0 | 0 | 0 | 0 | -6.758 | 13.18 | 23.956 | -31.906 | 4.359 | -4.067 |
| Overige Niet-Contante Posten
| 3.17 | 407.997 | 39.938 | 46.147 | 431.621 | 34.043 | -68.625 | -1.648 | 39.2 | -24.47 | -91.632 |
| Kasstroom uit Operationele Activiteiten
| 484.363 | 648.237 | 409.758 | 411.346 | 375.592 | 395.708 | 242.994 | 163.513 | 221.45 | 161.754 | 150.272 |
| Investeringsactiviteiten: | |||||||||||
| Investeringen in Materiële Vaste Activa
| -129.509 | -63.004 | -63.864 | -63.354 | -84.408 | -44.074 | -86.853 | -92.354 | -134.143 | -339.612 | -200.391 |
| Netto Overnames
| 9.12 | 10.475 | -11.347 | -199.802 | -107.251 | -370.46 | -36.814 | -789.144 | 0.412 | -52.076 | -16.473 |
| Aankoop van Beleggingen
| 0 | -1.557 | -50.578 | -144.041 | -260.277 | -185.247 | -196.074 | 711.452 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 135.327 | 10 | 73.545 | 51.009 | -0 | 12.416 | 232.888 | 77.692 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 28.404 | -72.888 | -0.51 | -19.213 | 0.187 | -39.42 | -241.544 | -2.37 | 0.008 | 0.717 | 90.335 |
| Kasstroom uit Investeringsactiviteiten
| 43.342 | -44.086 | -52.754 | -375.401 | -451.749 | -626.785 | -328.397 | -806.176 | -133.723 | -390.971 | -126.529 |
| Financieringsactiviteiten: | |||||||||||
| Schuldaflossingen
| -757.522 | 172.295 | -260.677 | 24.483 | 167.117 | -74.41 | -34.213 | 496.174 | -32.718 | 164.942 | -31.918 |
| Uitgifte van Gewone Aandelen
| 0 | 0 | 0 | 149.122 | 0 | 412 | 0 | 754.687 | 0 | 0 | 28.002 |
| Terugkoop van Gewone Aandelen
| -7.685 | -32.42 | 0 | -1.501 | -150.895 | 0 | 0 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| -93.603 | -104.028 | -51.723 | -63.217 | -100.232 | -88.687 | -41.76 | -239.325 | -1.8 | -9.628 | -1.8 |
| Overige Financieringsactiviteiten
| -272.241 | -72.445 | -45.488 | -89.033 | -49.057 | -42.706 | 457.517 | 662.594 | -33.068 | 5.539 | -3.031 |
| Kasstroom uit Financieringsactiviteiten
| -1,053.255 | -45.642 | -357.888 | 21.355 | -133.067 | 206.197 | 381.544 | 919.443 | -67.586 | 160.853 | -8.747 |
| Overige Informatie: | |||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 1.069 | -0.744 | -0.813 | 1.609 | 0.823 | -2.011 | 0.907 | -0.02 | -0.221 | -0.123 | -0.282 |
| Netto Kasstroomverandering
| -524.481 | 557.765 | -1.697 | 62.357 | -211.849 | -26.891 | 297.048 | 276.76 | 19.92 | -68.487 | 14.714 |
| Kaspositie aan het Einde van de Periode
| 411.937 | 1,036.418 | 478.653 | 480.35 | 417.993 | 629.842 | 656.733 | 359.685 | 82.925 | 63.005 | 131.492 |